Biogen Idec (BIIB) option implied volatility at 25 into Rituxan Safety Warning
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) : BIIB & DNA's Rituxan drug to treat lupus has resulted in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


